Guidelines in urology: Lights and shadows

Cai, Tommaso; Cocci, Andrea; Gacci, Mauro; Verze, Paolo; Bonkat, Gernot; Köves, B.; Wagenlehner, Florian M. E.; Bartoletti, Riccardo; Johansen, Truls E. Bjerklund

doi:10.1177/0391560320917805

Cited by 5 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the frequency of AC, there are errors frequently committed and discrepancies unresolved. Even though there are general guidelines concerning diagnosis and classification, a wide variation of approaches exists in clinical practice [5][6][7]. Approximately 50% of patients with AC will recover without treatment; however, if left untreated, some patients with AC may progress to develop a recurrent infection, pyelonephritis and rarely renal failure [3].…”

Section: Introductionmentioning

confidence: 99%

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

et al. 2021

View full text Add to dashboard Cite

The Acute Cystitis Symptom Score (ACSS) is a patient self-reporting questionnaire for the clinical diagnosis and patient-reported outcome (PRO) in women with acute uncomplicated cystitis (AC). The aim of the current study (part II) is the clinical validation of the Greek ACSS questionnaire. After linguistic validation according to internationally accepted guidelines and cognitive assessment (part I), the clinical validation was performed by using the Greek ACSS study version in 92 evaluable female participants including 53 patients with symptoms suspicious of AC and 39 controls. The clinical outcome using the ACSS questionnaire at different points in time after the start of treatment was demonstrated as well. The age (mean ± SD) of the 53 patients (44.7 ± 17.0 years) and 39 controls (49.3 ± 15.9 years) and their additional conditions at baseline visits, such as menstruation, premenstrual syndrome, pregnancy, menopause, diabetes mellitus, were comparable. There was, however, a significant difference (p < 0.001) between patients and controls at baseline visit regarding sum score of the ACSS domains, such as typical symptoms and quality of life. The clinical outcome of up to 7 days showed a fast reduction of the symptom scores and improvement of quality of life. The optimal thresholds for the patient-reported outcome of successful therapy could be established. The linguistically and clinically validated Greek ACSS questionnaire can now be used for clinical or epidemiological studies and also for patients’ self-diagnosis of AC and as a PRO measure tool.

show abstract

Section: Introductionmentioning

confidence: 99%

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Despite the frequency of AC, there are both: errors that are frequently committed and discrepancies that remain unresolved. Even though general guidelines concerning diagnosis and classification do exist, a wide variation of approaches exists in clinical practice [5][6][7]. Approximately 50% of patients with AC will recover without treatment; however, if left untreated, some patients with AC may progress to develop a recurrent infection, pyelonephritis, and rarely renal failure.…”

Section: Introductionmentioning

confidence: 99%

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS). Part II

Stamatiou¹,

Samara²,

Alidjanov³

et al. 2021

Preprint

View full text Add to dashboard Cite

The Acute Cystitis Symptom Score (ACSS) is a patient self-reporting questionnaire for the clinical diagnosis and patient-reported outcome (PRO) in women with acute uncomplicated cystitis (AC). The aim of the current study (part II) was the clinical validation of the Greek ACSS questionnaire. After linguistic validation according to internationally accepted guidelines and cognitive assessment (part I), the clinical validation was performed after ethical approval by using the Greek ACSS study version in 92 evaluable female participants including 53 patients with symptoms suspicious of AC and 39 controls. The clinical outcome using the ACSS questionnaire at different time points after the start of treatment was demonstrated as well. The age (mean±SD) of the 53 patients (44.7±17.0) and 39 controls (49.3±15.9) and their additional conditions at baseline visits, such as menstruation, premenstrual syndrome, pregnancy, menopause, diabetes mellitus, were comparable. There was, however, a significant difference (p&lt;0.001) between patients and controls at baseline visit regarding sum score of the ACSS domains, such as typical symptoms and quality of life. The clinical outcome of up to 7 days showed a fast reduction of the symptom scores and improvement of quality of life. The optimal thresholds for the patient-reported outcome of successful therapy could be established. The linguistically and clinically validated Greek ACSS questionnaire can now be used for clinical or epidemiological studies and also for patient’s self-diagnosis of AC and as a PRO measure tool.

show abstract

Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES–UTUC registry

et al. 2022

View full text Add to dashboard Cite

Guidelines in urology: Lights and shadows

Cited by 5 publications

References 15 publications

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS). Part II

Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES–UTUC registry

Contact Info

Product

Resources

About